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ABSTRACT 
Background: Pittaja Mukhapaka or the Aphthous ulcer is a painful and often recurrent 
inflammatory process of the oral mucosa that can appear secondary to various well-defined disease 
processes. Idiopathic recurrent aphthous stomatitis is referred to as recurrent aphthous stomatitis.  
Objectives: To evaluate the effect of Patoladi kashaya gandusha in Toda, Daha, Asyavairasyata and 
the pH of Pittaja mukhapaka (Aphthous ulcer) and to standardize the frequency of Gandusha (An 
Ayurvedic intervention). 
Design: This was a randomized controlled study with thirty patients divided into two groups, 15 in 
each. In Group A, Patoladi kashaya gandusha (gargling) was given once a day for 7 days and in 
Group B, Patoladi kashaya gandusha (gargling) was carried out twice a day for 7 days. After the 
completion of treatment, follow up was done once in fifteen days for a period of 2 months.  
Results: Statistically significant results were seen in reduction of Toda with p<0.001, Group A 
(61.53%) compared to Group B (81.81%), Daha with p<0.001 Group A (73.07%) compared to 
Group B (81.81%), Asyavairasyata with p<0.001 Group A (73.91%) compared to Group B (100%) 
and also in relieving the pH of saliva with p<0.001 and Group A (100%) compared to Group B 
(100%).  
Conclusions: Group B (Patoladi kashaya gandusha given twice a day) showed statistically 
significant results compared to Group A (Patoladi kashaya gandusha given once a day) in reduction 
of Toda, Daha, Asya vairasyata and the pH of Pittaja Mukhapaka (Aphthous ulcer).  
KEYWORDS: Pittaja Mukhapaka, Gandusha, Patoladi kashaya, Aphthous ulcer. 
INTRODUCTION 
Poor oral health may have a profound effect 
on general health and several oral diseases are 
related to chronic diseases (e.g. diabetes). WHO 
recently published a global review of oral health 
which emphasized that despite great improvements 
in the oral health of populations in several countries, 
global problems still persist. This is particularly so 
among underprivileged groups in both developing 
and developed countries. Oral diseases such as dental 
caries, periodontal disease, tooth loss, oral mucosal 
lesions and oropharyngeal cancers, human 
immunodeficiency virus/acquired immunodeficiency 
syndrome (HIV/AIDS) -related oral disease and 
orodental trauma are major public health problems 
worldwide. [1] 
Recurrent Aphthous Stomatitis (RAS) is a 
condition in which ulcers repeatedly occur in the oral 
cavity.[2] Aphthous ulcers arise in the oral cavity at 
least four times a year.3 It is prevalent in developed 
countries, occurring in all ages, geographic regions 
and races. [2,4] About 80% of people have one episode 
of oral aphthous ulcers before the age of 30 years.2 
Predisposing factors like trauma, deficiency of B-
complex vitamins and folate, microbial factors, stress, 
hormonal changes and immunologic factors may 
contribute to the formation of ulcers. [5, 6] 
Ulcers shows painful, shallow, round ulcers 
which have a pseudomembranous centre surrounded 
by an erythematous margin. Burning sensation is 
present for about 2 to 48 hours before the 
appearance of the ulcer.[5] Intense pain is present at 
the ulcer site and as healing occurs, the pain 
gradually recedes.[2] Most ulcers occur on the non-
keratinizing epithelial surface of the mouth like the 
buccal and labial mucosa and the tongue in three 
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forms such as are minor, major and herpetiform 
recurrent aphthous stomatitis. [2,5]  
Sixty five kinds of diseases affecting seven 
different sites of the oral cavity i.e. lips, the gums of 
the teeth, the teeth proper, the tongue, the palate, the 
throat and entire cavity has been described by 
Sushrutha, an Ayurvedic Surgeon. The one that 
occurs in the mucus membrane of the mouth is called 
as Mukhapaka or the Sarvasara mukharoga which 
can be compared to ulcerative stomatitis or Aphthous 
ulcers as per the modern medicine among which 
Pittaja mukhapaka is the most common. 
The fundamental goals of treatment are to 
shorten the duration of ulcer, provide relief from 
pain, and increase disease-free periods while the 
secondary goals would be to lessen the frequency 
and severity of recurrences. [7,8] Additionally, since 
recurrent aphthous stomatitis can significantly affect 
a person’s quality of life, efforts need to be made to 
bring forth a drug that can prevent recurrences as 
well. The same treatment regimen cannot be used in 
all patients as certain drugs appear to be effective in 
some, while others might have limited responses. [2] 
Topical therapy may be sufficient for occasional 
episodes of minor ulcers while systemic 
interventions are used in patients who are 
unresponsive to topical agents or have severe 
disease. [2,5,7]  
Corticosteroids are widely used to control 
aphthous lesions; however, even their topical 
application may be associated with some side 
effects.[9] 1% to 4% alum solution is used as 
mouthwash or gargle in the treatment of stomatitis 
and pharyngitis.[10] It has astringent and hemostatic 
properties when applied topically.[11,12] This causes 
contraction of tissues and enhances wound healing 
by decreasing the inflammation in the mucosal 
membrane.[13] Although numerous treatment 
modalities have been recommended, very few studies 
have aimed to find an effective treatment for RAS as a 
distinct clinical entity. Recently, herbal medications 
have been suggested for treatment of these lesions 
due to having minimal or no side effects. [14] 
Ayurveda, considered as one of the 
complementary and alternative medicine describes 
Kavala, Gandusha and Pratisarana etc local therapies 
for Pittaja mukhapaka or the Aphthous ulcer, among 
which Gandusha (gargling) is the most effective mode 
of local treatment for Mukhapaka. Though various 
works have been carried concerning the Pittaja 
mukapaka, Patoladi kashaya that is being described 
in Yogarathnakara samhitha[15] of Ayurveda was not 
studied. Considering the effectiveness, cost, easy and 
routine applicability, the present study was 
conducted to assess the efficacy of Patoladi kashaya 
in Aphthous ulcer or the Pittaja mukhapaka.  
MATERIALS AND METHODS  
The data were collected from the OPD and 
IPD of Shalakya Tantra, S.D.M college of Ayurveda 
and hospital Hassan. Patients with the features of 
Pittaja mukha paka (recurrent oral ulcers) with 
chronicity of less than 1 year and both males and 
females aged between 15 to 60yrs were included for 
the study. Patients with the features of other Doshaja 
and Agantuja mukha paka and also suffering from 
Grave’s diseases, AIDS, Oral cancer and diabetes 
mellitus were excluded from the study. 
Ethical clearance and consent 
The study was approved by the institutional 
ethical committee and signed informed consent was 
obtained from all patients. 
Design: In this randomized control study, 30 subjects 
who satisfied the study criteria were divided into two 
groups, Group A and Group B using a computer 
generated randomizer table (www.randomizer.org) 
with 15 patients in each group. Group A received 
Patoladi Kashaya Gandusha once a day for 7 days 
continuously and Group B received Patoladi Kashaya 
Gandusha twice a day for the same duration i.e., for 7 
days. Both the groups were followed once in fifteen 
days for a period of 2 months. Outcome variables 
were recorded before the treatment on 1st day and on 
15th day, 30th day 45th and 60th day after the 
treatment.  
Outcome measures 
Subjective parameters: Toda, Daha and Asya 
vairasyata were assessed before and after the 
treatment.  
Objective parameter: pH value of saliva was 
assessed by litmus paper before and after treatment.  
Table 1: Gradation Index 
Subjective Symptoms 
Toda 
No Toda 0 
Mild-Toda during churning of food 1 
Moderate-Toda during talking and gets relief by topical anaesthetics 2 
Severe- Toda even during rest, No relief by topical anaesthetics 3 
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Daha 
No Daha 0 
Mild-tolerable, no need of cooling agents Like glycerine or cold juice 1 
Moderate-intolerable, Gets relief by cooling agents 2 
Severe-intolerable, no relief by cooling agents 3 
Aasya Vairasyata 
Proper taste perception, enjoys taste of the food 0 
Often complains regarding the taste of food 1 
Shows disinterest towards food 2 
Often skips meal 3 
Objective Symptoms 
pH of Saliva 
7.0-7.5 Normal 0 
>7.5 Slightly Alkali 1 
<6.9-6.5 Slightly acidic 1 
>6.5 Strongly acidic 2 
INTERVENTION 
Group A  
The whole procedure was explained to the patient and was advised to complete his Pratah karmas 
(early morning chores) like Malavisarjana, Dantadhavana (brushing teeth) and Jihva Nirlekhana (tongue 
scraping) and to consume light food. Patient was made to sit in the most comfortable position and with calm 
mind. The freshly prepared warm Patoladi kvatha was given and asked to hold it in the mouth or the oral cavity 
(Mukha kuhara) to its full capacity with head slightly tilted upwards till the secretions were observed in Nasa 
(nose) and Netra (eyes) and the patient was asked to spit out the liquid and again fresh Kvatha was given for 
the second time to retain in the mouth. The same procedure was followed for 7 days in this group. After the 
completion of procedure, the patient was asked to wash his mouth with Sukoshna jala (warm water) and 
observations were made for Samyaka, Hina and Atiyoga lakshanas. Patient was also advised to avoid excessive 
exposure to wind and sun.  
Group B  
In this group, the same procedure of the intervention was followed but twice a day for 7 days.  
Follow up  
After the completion of treatment, all patients were advised to attend once in 15 days up to 2 months.  
RESULTS  
Thirty patients with features of Pittaja mukhapaka were registered for the study. In the present study, 
the incidence of Pittaja mukhapaka was more in 15-30 years (40%) age group, (57%) males, (80%) in Hindus, 
57% in rural habitat, 43% in manual workers, 64% in Pittavataja prakruti, 73% with mixed dietary habits, 40% 
in people having the habit of consuming tea. Pittaja mukhapaka showed maximum of 44% incidence in anemic 
patients, 90% had no family history, 56% were having the duration of Mukhapaka between 6-12 months, 64% 
had taken medical treatment, 34 % of them had Vrana in Jihwa, Gala and Ostha.  
Table 2: Demographic data 
S.No Demographic parameters  Group A Group B Total 
1. Age    
 15-30 yrs 6 6 12 
 31-45 yrs 4 6 10 
 46-60 yrs 5 3 08 
2. Sex    
 Males 10 07 17 
 Females 05 08 13 
3. Religion    
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 Hindu 12 12 24 
 Muslim  02 02 04 
 Christian 01 01 02 
4. Occupation     
 Sedentary 2 2 4 
 Manual 8 5 13 
 Labour 4 5 9 
 Student 1 3 4 
8. Prakruthi    
 Pittavataja 10 9 19 
 Pittakaphaja 2 4 6 
 Kaphavataja 3 2 5 
10. Habits    
 Smoking 4 2 6 
 Alcohol 0 1 1 
 Tobacco chewing 5 3 8 
 Tea/coffee 4 8 12 
 No habits 2 1 3 
11. Chronicity    
 1 month-6 month 9 4 13 
 6 months-12 months 6 11 17 
12.  Family history    
 Present 2 1 3 
 Absent 13 14 27 
13. Hygienic status    
 Poor 3 1 4 
 Moderate 2 1 3 
 Good 10 13 23 
14. Manasika bhavas (Psychological factors)     
 Chinta 4 1 5 
 Kroda 1 1 2 
 Chinta Krodha 7 5 12 
 Chinta Krodha Shoka 3 8 11 
15. Capacity of Kvatha    
 80-40 ml 8 8 16 
 41-50 ml 3 2 5 
 51-60 ml 2 3 5 
 61-70 ml 2 2 4 
16. Time duration    
 3-4 min 3 6 9 
 4-5 min 7 5 12 
 5-6 min 3 1 4 
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Table 3: Incidence of Symptoms 
  Group A Group B Total 
1. Associated Symptoms    
 Jwara 3 2 5 
 Shirashoola 2 1 3 
 Amlapitta 2 3 5 
 Malabadhata 3 1 4 
 Anaemia 5 8 13 
2. Site of Vrana    
 Ostha Jihva 6 3 9 
 Dantamoola 2 1 3 
 Jihva Gala 4 1 5 
 Jihva Ostha Gala 1 9 10 
 Taalu 2 1 3 
3.  pH of Saliva    
 Normal 7.0-7.5 4 1 5 
 Slightly Alkali>7.5 7 5 12 
 Slightly Acidic 6.5-6.9 4 9 13 
 Strongly Acidic<6.5 0 0 0 
Table 4: Severity of the Symptoms 
1. Severity of Toda Group A Group B Total 
 Mild 2 1 3 
 Moderate 8 6 14 
 Severe 5 8 13 
2. Severity of Daha    
 Mild 3 2 5 
 Moderate 7 6 13 
 Severe 5 7 12 
3. Severity of Asyavairasyata    
 Mild 4 2 6 
 Moderate 2 5 7 
 Severe 9 8 17 
Within Group Results (GROUP A)  
Toda 
 In Group A, before the treatment, the initial mean score of Toda was 2.2 and reduced to 0.4 after 7 days 
of the treatment with 81.81% of relief and statistical significance (p<0.001).  
Daha 
 In Group A, before the treatment, the initial mean score of Daha was 2.2 and reduced to 0.4 after 7 days 
of the treatment with 81.81% of relief and statistical significance (p<0.001).  
Asyavairasyata 
 In Group A, before the treatment, the initial mean score of Asyavairasya was 1.4 and reduced to 0.0 after 
7 days of the treatment with 100% of relief and statistical significance (p<0.001).  
pH 
 In Group A, before the treatment, the initial mean score of Asyavairasya was 0.7 and reduced to 0.0 after 
7 days of the treatment with 100% of relief and statistical significance (p<0.001).  
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Within Group Results (GROUP B)  
Toda 
 In Group B, before the treatment, the initial mean score of Toda was 2.6 and reduced to 1.0 after 7 days 
of the treatment with 61.53% of relief and statistical significance (p<0.001).  
Daha 
 In Group B, before the treatment, the initial mean score of Daha was 2.6 and reduced to 0.7 after 7 days 
of the treatment with 73.07% of relief and statistical significance (p<0.001). 
Asyavairasyata  
 In Group B, before the treatment, the initial mean score of Asyavairasya was 2.3 and reduced to 0.6 after 
7 days of the treatment with 73.91% of relief and statistical significance (p<0.001).  
pH 
 In Group B, before the treatment, the initial mean score of Asyavairasya was 0.9 and reduced to 0.0 after 
7 days of the treatment with 100% of relief and statistical significance (p<0.001).  
Table 5: Within Group Results (Group B)  













Value BT AT 




AT 2.2 0.4 1.8 81.81 0.77 0.18 14 10.00 <0.001 
FU 1 2.2 1.6 0.6 27.27 0.50 0.12 14  5.00 <0.001 
FU 2 2.2 1.2 0.9 40.90 0.59 0.15 14  6.00 <0.001 
FU 3 2.2 1.6 0.6 22.72 0.63 0.16 14  3.12 <0.001 
FU 4 2.2 1.6 0.6 22.72 0.63 0.16 14  3.12 <0.001 




AT 2.2 0.4 1.8 81.81 0.67 0.17 14 10.58 <0.001 
FU 1 2.2 1.6 0.6 27.27 0.50 0.12 14  5.00 <0.001 
FU 2 2.2 1.2 0.9 40.91 0.59 0.15 14  6.00 <0.001 
FU 3 2.2 1.4 0.8 31.81 0.45 0.11 14  6.36 <0.001 
FU 4 2.2 1.4 0.8 36.30 0.45 0.11 14  6.36 <0.001 
Asyavairasya          
 AT 1.4 0.0 1.4 100 0.50 0.12 14 11.6 <0.001 
FU 1 1.4 0.7 0.7 50.00 2.59 0.66 14 0.90 <0.10 
FU 2 1.4 0.2 1.1  7.85 0.83 0.21 14 5.23 <0.001 
 FU 3 1.4 0.1 1.2 85.71 0.70 0.18 14 6.66 <0.001 
FU 4 1.4 0.4 1.0 71.40 0.37 0.09 14 11.1 <0.001 




AT 0.7 0.0 0.7 100 0.45 0.11 14 6.36 <0.001 
FU 1 0.7 0.0 0.7 100 0.45 0.11 14 6.36 <0.001 
FU 2 0.7 0.0 0.7 100 0.45 0.11 14 6.36 <0.001 
FU 3 0.7 0.0 0.7 100 0.45 0.11 14 6.36 <0.001 
FU 4 0.7 0.0 0.7 100 0.45 0.11 14 6.36 <0.001 
Table 6: Within Group Results (Group A)  













Value BT AT 
Toda          
P 
K 
AT 2.6 1.0 1.6 61.53 0.48 0.12 14 13.3 <0.001 
FU 1 2.6 1.9 0.7 26.92 0.45 0.11 14  6.36 <0.001 
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B FU 2 2.6 2.5 0.2  7.69 0.56 0.14 14  1.42 <0.10 
FU 3 2.6 1.8 0.8 30.76 0.56 0.14 14  5.71 <0.001 
FU 4 2.6 1.6 1.0  6.66 0.53 0.13 14  7.69 <0.001 




AT 2.6 0.7 1.9 73.07 0.25 0.06 14 31.6 <0.001 
FU 1 2.6 1.4 1.2 46.25 0.88 0.22 14  5.45 <0.001 
FU 2 2.6 2.5 0.2  7.69 0.56 0.14 14  1.42 <0.10 
FU 3 2.6 1.8 0.8 30.76 0.56 0.14 14  5.71 <0.001 
FU 4 2.6 1.6 1.0 38.46 0.53 0.13 14  7.69 <0.001 




AT 2.3 0.6 1.7 73.91 0.59 0.15 14 11.3 <0.001 
FU 1 2.3 0.4 1.9 82.60 1.22 0.31 14 6.12 <0.001 
FU 2 2.3 0.9 1.4 60.86 0.82 0.21 14 6.66 <0.001 
FU 3 2.3 0.7 1.5 65.21 0.74 0.19 14 7.89 <0.001 
FU 4 2.3 1.7 0.6 26.08 0.50 0.12 14 5.00 <0.001 




AT 0.9 0.0 0.9 100 0.25 0.06 14 15.0 <0.001 
FU 1 0.9 0.0 0.9 100 0.25 0.06 14 15.0 <0.001 
FU 2 0.9 0.0 0.9 100 0.25 0.06 14 15.0 <0.001 
FU 3 0.9 0.0 0.9 100 0.25 0.06 14 15.0 <0.001 
FU 4 0.9 0.0 0.9 100 0.25 0.06 14 15.0 <0.001 
Table 7: Results between groups 
Overall  
Improvement / Relief (in %)  
Group A Group B 
Pts % Pts % 
Complete Remission 01 07 05 33 
Marked Relief 00 00 00 00 
Moderate Relief 09 60 02 13 
Mild Relief 03 20 08 54 
No Relief 02 13 00 00 
Follow Up 
Toda 
 In Group A, follow up was done on 15th day, 30th day, 45th day and 60th day at an interval of 15 days and 
showed the changes with mild variation (27.27%, 40.90%, 22.72%, and 22.72%). Whereas in Group B, follow 
up that was done on 15th day, 30th day, 45th day and 60th day at an interval of 15 days showed the changes with 
mild variation (26.92%, 07.69%, 30.76%, and 06.66%). 
Daha 
 In Group A, follow up that was done on 15th day, 30th day, 45th day and 60th day at an interval of 15 days 
showed the changes with mild variation (27.27%, 40.91%, 31.81%, and 36.30%). Whereas in Group B, Follow 
up that was done on 15th day, 30th day, 45th day and 60th day at an interval of 15 days showed the changes with 
mild variation (46.25%, 7.69%, 30.76%, and 38.46%).  
Asyavairasyata 
 In Group A, follow up that was done on 15th day, 30th day, 45th day and 60th day at an interval of 15 days 
showed the changes with mild variation (50%, 7.85%, 85.71%, and 71.40%). Whereas in Group B, Follow up 
that was done on 15th day, 30th day, 45th day and 60th day at an interval of 15 days showed the changes with 
mild variation (82.60%, 60.86%, 65.21%, and 26.08%).  
pH  
 In Group A, follow up that was done on 15th day, 30th day, 45th day and 60th day at an interval of 15 days 
showed the changes with mild variation (100%, 100%, 100%, and 100%).  
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In Group B, follow up that was done on 15th day, 30th day, 45th day and 60th day at an interval of 15 days showed 
the changes with mild variation (100%, 100%, 100%, and 100%).  
Overall  
 In Group A, follow up that was done on 15th day, 30th day, 45th day and 60th day at an interval of 15 days 
showed the changes with mild variation (71.42%, 28.57%, 42.85%, and 57.14%).  
In Group B, follow up that was done on 15th day, 30th day, 45th day and 60th day at an interval of 15 days showed 
the changes with mild variation (100%, 100%, 100%, and 100%).  
Table 8: Results after the treatment and Follow up (Group A & Group B) 
Percentage Improvement/ 
Relief (in %)  
Group A Group B 
AT FU AT FU 
Toda 81.81 22.72 61.53 6.66 
Daha 81.81 36.30 73.07 38.40 
Asyavairasyata 100 71.40 73.91 26.08 
pH of saliva 100 100 100 100 
 Group A showed statistically significant 
results (81.81%) compared to Group B (61.53) in 
relieving the severity of Toda with p<0.001, Group A 
(81.81%) compared to Group B (73.07%) in Daha 
with p<0.001, Group A (100%) compared to Group B 
(73.91%) in Asyavairasyata with p<0.001 and Group 
A (100.00%) compared to Group B (100.00%) in 
relieving the severity of pH of saliva with p<0.001.  
DISCUSSION 
Mukhapaka is a condition characterized by 
Vedana Yukta Vrana (Shopha) in the Mukha Kuhara 
Pratyangas like Kapola, Oshta, Jiwha, Danta, Mamsa 
and Talu. The Lakshanas of Mukhapaka can be 
correlated to a clinical entity “Aphthous Ulcer” 
(recurrent ulcerative stomatitis) explained in the 
contemporary medical science, which is also 
characterized by painful superficial ulcers in the 
movable mucosa of the mouth with recurrent 
episodes. Mukhapaka is neither a serious disorder 
nor one that can be dismissed as cursory. It is not life 
threatening, but at the same time it can be crippling 
by grossly disturbing the individual’s life style. It is a 
disorder of such kind, which gravely upset s the work 
output of the country’s labor force, and has a 
disabling effect on the national economy. 16  
In this study 30 patients of Pittaja mukhapaka 
were treated in two groups each comprising of 15 
patients. Gandusha was done with Patoladi kashaya 
once in a day in PKA group while twice in day in PKB 
group to ascertain whether the increase in the 
frequency of Gandusha provides better relief. 40% 
patients were in the age group of 15-30 years, 
followed by 34% in the group of 31-45 years. In 
Ayurveda, 15-40 years age is considered as Yauvana 
kala (youth) where Pitta is at its peak level. In Pittaja 
mukhapaka the same Pitta acts as Rogarambhaka 
dosha (causative factor). Male patients were 57% 
compared to females 43% showing that the females 
have inherent resistance due to the periodical 
menstrual bleeding that prevents the Rakta dushti, 
the major cause of Pittaja mukhapaka. Pitta disorders 
are found more in Pitta prakruti persons and in the 
present study, 64% patients were of Vata pitta 
prakruti with 20% Pitta kaphaja and 16% of Kapha 
vataja.  
Regarding the diet pattern in the present 
study, maximum numbers of patients were having 
the habit of mixed diet with addictions of consuming 
excess tea/coffee-40%, tobacco chewing-26%, 
smoking-20% and alcohol-04% and 44% patients 
were having anemic. Maximum of 40% patients were 
afflicted with Chinta (stress) and Kroda (anger) 
which are said to be the strong influencing factors for 
the causation of Pittaja mukhapaka. As per the 
Ayurvedic science, Tikta (bitter) and Madhura 
(sweet) Rasa (tastes) influences Kapha dosha and 
Amla (sour) and Katu (pungent) Rasa vitiates Pitta 
dosha and therefore Kapha and Pitta dosha becomes 
the causative factor of the disease. In the present 
study, Ahara rasa preferred by the patients were 
Tikta-36%, Madhura-23%, Amla-17%, Katu-10% and 
Lavana-04%.  
In the present study, 43% of patients had 
their saliva slightly acidic, 40% of patients had 
slightly alkaline saliva and remaining 17% patients 
had normal pH of their saliva. 56% of patients were 
suffering for 6 months to 1 year and 44% of patients 
were suffering for 1 month to 6 month, which forms 
the most important factor as usually this is neglected 
up to 6 months to 1 year. In 34% of patients, Vrana 
was seen in Jihva, Ostha and Gala 30% in Ostha and 
Jihva, 16% in Jihva and Gala and equal in Taalu and 
Dantamoola (10%).  
This study also aimed to ascertain the 
maximum quantity of the liquid a person can hold in 
the mouth and for which, the quantity held by each 
patient was measured. It was found that 53% 
patients had the capacity of holding the liquid in their 
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mouth upto 30 to 40 ml, 17% patients with 41-60ml, 
16% patients with 51-60ml and 16% patients with 
61-70ml. Thus the average quantity of liquid filled in 
mouth (in 70% of patients) was ranging from 80-120 
ml depending upon the size of mouth. 40% patients 
had the commencement of Srava in Mukha within 4-5 
min, 30% patients showed secretion within 3-4 min, 
and 17% patients in 6-7 min and 13% patients in 5-6 
min. Based on this observation it was inferred from 
the present study that the average time (in 70% of 
patients of initiation of Srava ranges from 4 minute to 
5 minutes. With respect to the appearance of Srava in 
Mukha, Nasa and Netra, 40% of the patients showed 
secretion only in Mukha, 26% patients in Mukha and 
Nasa, 20% patients in Mukha and Netra, 14% 
patients showed secretion in all the three i.e., Mukha, 
Nasa and Netra which is also found in the Shastra as 
the liquid should be retained in the mouth till the 
secretions are observed in Mukha, Nasa, and Netra.  
RAS is classified into 3 types according to the 
diameter of the lesion, namely, the minor, major, and 
herpetiform aphthous ulcerations. The most common 
form of RAS is minor aphthous ulcerations, and the 
minor form is, respectively, followed by major and 
herpetiform ulcerations.17 The etiology of RAS still 
remains unknown. These ulcerations may be 
indicative of underlying systemic diseases ranging 
from vitamin deficiency to autoimmunity.18 
Recurrent Aphthous Stomatitis has been 
described as presenting in three forms including 
minor aphthae, major aphthae and herpetiform 
aphthae. 19 Minor aphthae account for 75-85 percent 
of all RAS cases and can involve any non-keratinized 
mucosa of the oral cavity. The characteristic lesions 
are smaller than 10 millimeters and heal within 7-14 
days without scarring. Major aphthae, comprising 10-
15 percent of RAS cases, are larger, of longer 
duration, are more intense than minor aphthae, and 
tend to leave scars after healing. The herpetiform 
ulcers represent only 5-10 percent of RAS cases and 
consist of multiple 1-3 mm painful ulcers resembling 
herpes simplex, but involving non-keratinized 
mucosa.20 Other topical approaches for the 
management of RAS have been studied. Topical 
steroids such as triamcinolone acetonide in 
carboxymethylcellulose paste have been used for 
years.21  
Topical betamethasone 22 and fluocinonide 23 
are also suggested for management of RAS. Transient 
relief of pain was reported with benzydamine 
hydrochloride mouthwash, but it was not more 
effective than placebo on ulcer healing.24 Hunter et 
al25 reported that chlorhexidine gluconate 
mouthwash was not better than placebo and no 
significant difference in pain was recorded. Similar 
results were also reported by others.26,24 The use of 
Listerine mouth rinse for RAS 27 did not show benefit 
compared to the control. Topical sucralfate was 
effective in managing discomfort associated with RAS 
28 A trial of chlortetracycline mouthwashes on RAS 29 
reported significant reduction in duration of the 
ulcers with no side effects; however, pain was not 
assessed in this study. 
Whereas in the present study, Group B 
(Patoladi kashaya gandusha given twice a day) 
showed statistically significant results compared to 
Group A (Patoladi kashaya gandusha given once a 
day) in reduction of Toda, Daha, Asya vairasyata and 
the pH of Pittaja Mukhapaka (Aphthous ulcer).  
Effect of Patoladi Kashaya Gandusha (Group A)  
7 days Gandusha done with Patoladi Kashaya 
done twice a day provided significant relief in Toda 
by 07%, in Daha by 27%, in Asyavairasya by 40% and 
in pH of Saliva by 100%. In this group complete relief 
was found in 33% patients, moderate relief in 13% 
patients and mild improvement 54% patients.  
Effect of Patoladi Kashaya Gandusha (Group B)  
7 days Gandusha done with Patoladi Kashaya 
once in a day provided significant relief in Toda by 
67%, in Daha by 67%, in Asyavairasya by 100%, and 
in pH of Saliva by 100%. In this group complete relief 
was found in 07% patients, moderate improvement 
in 60% patients, mild improvement in 20% patients 
and no relief in 13% patients. On the basis of above 
results it can be inferred that as PKB Gandusha 
provided better relief in all the symptoms of Pittaja 
Mukhapaka in comparison to PKA Gandusha. 
Patoladi Kashaya drug is effective in both the 
groups. But the complete improvement, mild 
improvement is marked in the individual groups 
where as 100% response is observed in PKB i.e. 
Patoladi Kashaya Gandusha twice in a day. That is 
why PKB is more effective than the PKA group. 
Mechanism of Gandusha  
The action of Gandusha exerts increased 
mechanical pressure inside the oral cavity. So this 
increased pressure stimulates pressoreceptor 
(stretch reflex) that are present in the mouth. Once 
the pressoreceptor is stimulated, they send signals to 
salivary nuclei in the brain stem (pons and medulla). 
As a result, Parasympathetic nervous system activity 
increases and motor fibres in facial (VII) and 
glossopharyngeal (IX) nerve trigger dramatically 
increasing the output of saliva. Chemical constituent 
present in the drug also stimulate chemoreceptors 
present in the mouth, which in turn increases 
salivary secretions. An enzyme called lysozyme 
present in saliva is bacteriostatic in action. It 
prevents the growth of pathogenic microorganisms 
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in the oral cavity. Antibody IgA present in saliva also 
provide protection against microorganisms. Thus 
Gandusha increases local defence mechanism and 
promotes oral hygiene. Mucosal layer inferior to the 
tongue (sublingual) is thin and highly vascular 
enough to permit the rapid absorption of the lipid 
soluble drugs into systemic circulation. Some of the 
drugs irritates the oral mucosa (by their chemical 
nature) and increases vascular permeability. Thus an 
active principle of Dravya is absorbed into systemic 
circulation. Most of the Dravas given for Gandusha 
are Sukhoshna (warm) so raised temperature causes 
the increased vascular permeability thereby 
enhancing systemic absorption of drugs. 30  
Kavala and Gandusha are the two main oral 
cleansing procedures explained in the classics. These 
are not only the cleansing techniques, but also the 
treatment procedures for oral diseases as well as 
preventive measures. Daily practice of Gandusha 
helps in preventing the conditions like 
Mukhavairasya, Durgandha (bad odour), Shopha 
(swelling), Jadya, and strengthens the teeth. One who 
practices Thaila (oil) Gandusha regularly will not 
suffer from Kantashosha (dryness of mouth), 
Oshtasputana (cracking lips), Dantakshaya (loss of 
teeth), Dantashula (dental pain) and Dantaharsha 
(sensitivity).  
Gandusha is other form of drug 
administration into the oral cavity in which the active 
ingredients and chemical constituents of the drugs 
are absorbed through the buccal mucosa and reach 
the blood stream. It is having both in local and 
systemic action but generally more in local effect. 
Gandusha stimulates the salivary glands to secrete 
more saliva. Saliva contains a variety of host defence 
factors. The IgA, IgM antibodies and lysozyme (a 
bactericidal enzyme that inhibits bacterial growth in 
the mouth) present in the saliva provide protection 
against micro-organisms by acting as local antibiotic. 
Saliva also contains coagulation factors (factors VIII, 
IX&X) which protect wounds from bacterial invasion. 
Hence, Gandusha increases the local defence 
mechanism of the oral cavity and helps to regain oral 
hygiene. Gandusha increases the vascular 
permeability in the oral cavity. It creates pressure 
over the oral mucosa. The active ingredients and 
chemical constituents of the warm medicated liquid 
irritate the oral mucosa and increase the vascular 
permeability. Therefore, the drugs get rapidly 
absorbed both locally and systemically. This can help 
to reduce inflammation and enhance the healing 
process of disease and thus cures the disease of oral 
cavity. The main function of salivary buffer is to 
maintain pH at the mucosal epithelial cell surface and 
the tooth surface. Healthy mouth is a non-acidic or 
neutral. Unhealthy mouth is acidic and increases the 
risk of oral diseases. Gandusha is an immediate 
solution for mouth acidity and change the oral pH 
quickly into a safe zone. The active ingredients and 
chemical constituents of the medicated liquid of 
Gandusha regulate and balance the pH of the oral 
cavity and help to reduce bacterial growth in the 
mouth. Thus Gandusha cures the disease and helps to 
regain oral hygiene by maintaining a good pH balance 
in the mouth. 31 
Duration of Gandusha 
In a study of Nagatake T. et al, The subjects 
included a total of 23 adult patients, both males and 
females, with chronic respiratory diseases showing 
repeated infections. Patients were asked to gargle 
more than 4 times/day with povidone-iodine gargle 
over extended periods of time, i.e., from several 
months up to over 2 years. The incidence of episodes 
of acute exacerbation of chronic respiratory 
infections decreased significantly when compared 
with that before use of povidone-iodine gargle. 32 
In the observational study of Tatsuya Noda et 
al, the children were enrolled from 145 nursery 
schools in Fukuoka City, Japan and were instructed to 
gargle at least once a day. The endpoints of this study 
were incidence of fever during the daytime and 
incidence of sickness absence. Differences among 
gargling agents for each endpoint were also analyzed, 
where another explanation was suggested by a 
randomized clinical trial showing that oral rinsing 
with chlorhexidine gluconate for 30 seconds twice a 
day reduced the total nosocomial respiratory 
infection rate among patients in a cardiovascular 
intensive care unit. 33 
Regarding gargling agents, we found that 
gargling with green tea had a greater impact on 
febrile disease. The results of a prospective cohort 
study of the effect of gargling with green tea 
suggested that such gargling lowers the risk of 
influenza infection, although the effect was not 
significant in that study. 34  
Tea catechin is a type of flavonoid in green 
tea and has antiviral and bacteriocidal effects. 35-38 In 
a previous clinical study, gargling with a catechin 
extract of green tea inhibited influenza infection, and 
application of green tea extract to the oral or nasal 
cavities suppressed various pathogenic bacteria. 39, 40  
CONCLUSIONS  
Patoladi kashaya gandusha given twice a day 
showed statistically significant results compared to 
Patoladi kashaya gandusha given once a day in 
reduction of Toda, Daha, Asya vairasyata and the pH 
of Pittaja Mukhapaka (Aphthous ulcer).  
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